Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Cancer Research
|
April 15, 2022
Editor's Note: miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance
Lei Zhang, Karen Pickard, Veronika Jenei, et al.
Molecular Cancer Therapeutics
|
September 20, 2013
Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines
Marion Enthammer, Emmanouil S Papadakis, Maria Salomé Gachet, et al.
Oncotarget
|
June 21, 2015
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
Bashar Zeidan, Thomas R Jackson, Samantha E T Larkin, et al.
Leukemia
|
August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncogene
|
May 4, 2004
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage
Jorg Michels, Jason W O'Neill, Claire L Dallman, et al.
Cancer Cell International
|
May 16, 2018
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
Sergio Regufe da Mota, Sarah Bailey, Rosemary A Strivens, et al.
Leukemia
|
December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncogene
|
August 7, 2003
The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription
Ramsey I Cutress, Paul A Townsend, Adam Sharp, et al.
Journal of Medicinal Chemistry
|
September 2, 2005
E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1
Delphine S Fischer, Gillian M Allan, Christian Bubert, et al.
Scientific Reports
|
June 4, 2021
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
Beatriz Valle-Argos, Giorgia Chiodin, Dean J Bryant, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Cancer Research
|
April 15, 2022
Editor's Note: miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance
Lei Zhang, Karen Pickard, Veronika Jenei, et al.
Molecular Cancer Therapeutics
|
September 20, 2013
Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines
Marion Enthammer, Emmanouil S Papadakis, Maria Salomé Gachet, et al.
Oncotarget
|
June 21, 2015
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
Bashar Zeidan, Thomas R Jackson, Samantha E T Larkin, et al.
Leukemia
|
August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncogene
|
May 4, 2004
Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage
Jorg Michels, Jason W O'Neill, Claire L Dallman, et al.
Cancer Cell International
|
May 16, 2018
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
Sergio Regufe da Mota, Sarah Bailey, Rosemary A Strivens, et al.
Leukemia
|
December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncogene
|
August 7, 2003
The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription
Ramsey I Cutress, Paul A Townsend, Adam Sharp, et al.
Journal of Medicinal Chemistry
|
September 2, 2005
E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1
Delphine S Fischer, Gillian M Allan, Christian Bubert, et al.
Scientific Reports
|
June 4, 2021
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
Beatriz Valle-Argos, Giorgia Chiodin, Dean J Bryant, et al.
Page
of 13